Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System...

Area of Science:

• Pharmacology and Healthcare Quality Improvement

Background:

• Clinical pharmacologists aim to enhance medication use and reduce errors and adverse drug reactions.
• Quality improvement necessitates categorizing, measuring, and tracking key performance parameters.
• Medical malpractice data offers a valuable source for understanding medication errors and adverse events.

Purpose of the Study:

• To examine the significance and trends of medication claims and events reported between 1996 and 1998.
• To utilize insurance industry data for quality improvement in medication delivery and patient safety.
• To identify patterns in errors related to low therapeutic index and high-risk medications.

Main Methods:

• Analysis of PHICO's Closed Claims Data and Event Reporting Trending System (PERTS) from 1996-1998.
• Categorization of reported claims and events for reengineering medication delivery protocols.
• Comparison of PHICO data with established reporting systems like MedMARx and Joint Commission's Sentinel Event.

Main Results:

• Identified trends in medication errors and adverse drug reactions from insurance claims data.
• Highlighted the financial impact of adverse drug reactions ($2500) and preventable errors ($4700).
• Demonstrated the similarity of PHICO-reported events to those in other major reporting systems.

Conclusions:

• Categorizing and evaluating adverse drug event data is crucial for improving pharmacotherapy quality and patient safety.
• Insights from malpractice data can inform the redesign of drug administration protocols, especially for high-risk medications.
• Proactive monitoring, patient education, and careful titration are essential when using high-risk drugs to minimize adverse effects.